Article
Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell Function.
Cell reports - 24 Jan 2017
Mgbemena Victoria E, Signer Robert A J, Wijayatunge Ranjula, Laxson Travis, Morrison Sean J, Ross Theodora S
Abstract excerpt
BRCA1 is a well-known DNA repair pathway component and a tissue-specific tumor suppressor. However, its role in hematopoiesis is uncertain. Here, we report that a cohort of patients heterozygous for BRCA1 mutations experienced more hematopoietic toxicity from chemotherapy than those with BRCA2 mutations. To test whether this reflects a requirement for BRCA1 in hematopoiesis, we generated mice with Brca1 mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
